Predictive Oncology Inc. (POAI)

Predictive Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	13	24	62	13	10
Market Cap Growth	-60.07%	-44.64%	-61.32%	382.42%	27.51%	16.33%
Enterprise Value	2	7	2	35	18	16
PE Ratio	-	-0.96	-0.94	-3.18	-0.49	-0.52
PS Ratio	2.13	7.51	16.04	43.94	10.33	7.19
PB Ratio	1.03	1.62	1.11	1.55	4.90	0.90
P/FCF Ratio	-0.77	-0.99	-1.89	-4.76	-1.05	-1.16
P/OCF Ratio	-0.79	-1.01	-1.95	-5.11	-1.06	-1.16
EV/Sales Ratio	0.81	4.21	1.50	24.71	14.48	11.00
EV/EBITDA Ratio	-0.55	-0.57	-0.09	-1.85	-0.73	-0.83
EV/EBIT Ratio	-0.53	-0.54	-0.09	-1.73	-0.70	-0.80
EV/FCF Ratio	-0.58	-0.56	-0.18	-2.68	-1.47	-1.78
Debt / Equity Ratio	0.64	0.35	0.01	0.02	2.22	0.49
Debt / EBITDA Ratio	-0.18	-0.22	-0.01	-0.05	-0.24	-0.30
Debt / FCF Ratio	-0.19	-0.21	-0.01	-0.07	-0.48	-0.63
Quick Ratio	1.26	2.29	5.77	8.81	0.10	0.04
Current Ratio	1.45	2.55	6.02	9.09	0.16	0.07
Asset Turnover	0.12	0.09	0.04	0.03	0.06	0.06
Return on Equity (ROE)	-152.80%	-105.20%	-84.30%	-44.50%	-286.40%	-145.00%
Return on Assets (ROA)	-92.20%	-71.20%	-76.00%	-41.10%	-116.50%	-85.90%
Return on Capital (ROIC)	-224.09%	-127.14%	-118.65%	-50.23%	-326.25%	-155.83%
Earnings Yield	-353.27%	-104.61%	-106.59%	-31.49%	-204.33%	-193.95%
FCF Yield	-321.05%	-100.73%	-52.97%	-21.02%	-95.54%	-86.11%
Buyback Yield / Dilution	-2.39%	-8.92%	-34.34%	-359.21%	-316.36%	-123.95%
Total Shareholder Return	-2.39%	-8.92%	-34.34%	-359.21%	-316.36%	-123.95%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).